Having multiple treatment options is the kind of advancement we’ve all been waiting for ... scientists and clinicians ...

The Alzheimer’s disease market is expected to grow at a CAGR of 23.4% from $2.4bn in 2023 to $19.3bn by 2033 across the 8MM ...

Alzheimer's disease begins with a long period during which abnormal amyloid and tau proteins build up in the brain without ...

New expensive but disease-modifying treatments are expected to foster Alzheimer’s disease market growth globally, according to a report. The report by GlobalData, a data and analytics company, showed ...

The treatment is not a permanent fix for Alzheimer's dementia, Jing said, because the disease will eventually ... It's important for them to know there are options out there." ...

A groundbreaking discovery by scientists at Japan’s RIKEN Center for Brain Science has revealed an unexpected link between dopamine and Alzheimer’s disease ... s treatment stems from its ...

Having multiple treatment options is the kind of advancement ... showed physical changes that happen in the brain due to Alzheimer’s disease. “Defining diseases by the biology has long been ...

"These findings reveal a critical link between cellular stress and the neurotoxic effects of microglia in Alzheimer's disease." "Targeting this pathway may open up new avenues for treatment by ...

Former study was recently accepted in a peer-reviewed medical journal with focus on Alzheimer’s disease titled, “Blarcamesine for the treatment of Early Alzheimer’s Disease: Results from the ...

Blarcamesine is an orally once daily administered small molecule for the potential treatment of patients with Alzheimer’s disease. “The EMA filing acceptance for blarcamesine to review the ...

For decades, scientists have been trying to develop therapeutics for people living with Alzheimer’s disease, a progressive ...